Sample Summary Adverse Events Dataset
|
|
|
|
|
|
AEDECOD
|
AEBODSYS
|
COUNT_PT
|
NUM_NSAE
|
NUM_SAE
|
NUM_SUB
|
TRTAN
|
TRTA
|
TRT_DESC
|
VERSION
|
AESER
|
Headache
|
Nervous system disorders
|
4
|
3
|
1
|
40
|
1
|
Drug A
|
Study Drug
|
MedDRA 17.0
|
No
|
Back pain
|
Musculoskeletal and connective
tissue disorders |
16
|
12
|
5
|
40
|
1
|
Drug A
|
Study Drug
|
MedDRA 17.1
|
No
|
Hypotension
|
Vascular disorders
|
7
|
5
|
3
|
50
|
2
|
Drug B
|
Comparator Drug
|
MedDRA 17.1
|
Yes
|
Abdominal discomfort
|
Gastrointestinal disorders
|
8
|
8
|
6
|
60
|
3
|
Drug C
|
Comparator Drug
|
MedDRA 17.1
|
No
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Corresponding Data Entry for Summary AE
|
Preferred Term
|
AEDECOD
|
System Organ Class
|
AEBODSYS
|
Number of Subjects Per Preferred Term
|
COUNT_PT
|
Treatment Group /Arm ID (Optional)
|
TRTAN
|
Treatment Group / Arm
|
TRTA
|
Treatment / Arm Description (Optional)
|
TRT_DESC
|
Meddra Version
|
VERSION
|
Total Number of subjects affected by Non-Serious AEs per Treatment Group
|
NUM_NSAE
|
Total Number of subjects affected by Serious AEs per Treatment Group
|
NUM_SAE
|
Number of Subjects At Risk Per Treatment Group
|
NUM_SUB
|
Serious Adverse Events
|
AESER
|
Serious flag value (ex:"Serious" , "Yes" , 1, etc..)
|
YES
|
Non-Serious flag value (ex:"Non-Serious", "No", 2 , etc..)
|
NO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Exposure Data
|
SUBJID
|
TREATAN
|
TREATA
|
TREAT_DESC
|
XYZ-001-001
|
1
|
Drug A
|
Study Drug
|
XYZ-001-002
|
1
|
Drug A
|
Study Drug
|
XYZ-001-003
|
2
|
Drug B
|
Comparator Drug
|
XYZ-001-004
|
3
|
Drug C
|
Comparator Drug
|
XYZ-001-005
|
3
|
Drug C
|
Comparator Drug
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Corresponding Data Entry for Treatment
|
Subject Identification
|
SUBJID
|
Treatment Group / Arm
|
TREATA
|
Treatment Group / Arm ID (Optional)
|
TREATAN
|
Treatment Description
|
TREAT_DESC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Baseline Characteristics Dataset
|
|
|
|
|
|
|
|
PARAM
|
ARM_GROUP_ID
|
ARM_GROUP_TITLE
|
AVAL
|
MEASURE_TITLE
|
UNITOFM
|
|
|
FEMALE
|
1
|
Treatment Arm 1
|
2
|
Gender, Male/Female
|
Participants
|
|
FEMALE
|
2
|
Treatment Arm 2
|
101
|
Gender, Male/Female
|
Participants
|
|
FEMALE
|
99999999
|
Total
|
103
|
Gender, Male/Female
|
Participants
|
|
MALE
|
1
|
Treatment Arm 1
|
1
|
Gender, Male/Female
|
Participants
|
|
MALE
|
2
|
Treatment Arm 2
|
95
|
Gender, Male/Female
|
Participants
|
|
MALE
|
99999999
|
Total
|
96
|
Gender, Male/Female
|
Participants
|
|
< 18 weeks
|
1
|
Treatment Arm 1
|
3
|
Age, Customized
|
Participants
|
|
< 18 weeks
|
2
|
Treatment Arm 2
|
196
|
Age, Customized
|
Participants
|
|
< 18 weeks
|
99999999
|
Total
|
199
|
Age, Customized
|
Participants
|
|
45-64 weeks
|
1
|
Treatment Arm 1
|
0
|
Age, Customized
|
Participants
|
|
45-64 weeks
|
2
|
Treatment Arm 2
|
0
|
Age, Customized
|
Participants
|
|
45-64 weeks
|
99999999
|
Total
|
0
|
Age, Customized
|
Participants
|
|
>= 65 weeks
|
1
|
Treatment Arm 1
|
0
|
Age, Customized
|
Participants
|
|
>= 65 weeks
|
2
|
Treatment Arm 2
|
0
|
Age, Customized
|
Participants
|
|
>= 65 weeks
|
99999999
|
Total
|
0
|
Age, Customized
|
Participants
|
|
Mean Age
|
1
|
Treatment Arm 1
|
8.7
|
Age Continuous
|
weeks
|
|
Standard Deviation Age
|
1
|
Treatment Arm 1
|
2.5
|
Age Continuous
|
weeks
|
|
Mean Age
|
2
|
Treatment Arm 2
|
8.9
|
Age Continuous
|
weeks
|
|
Standard Deviation Age
|
2
|
Treatment Arm 2
|
2.3
|
Age Continuous
|
weeks
|
|
Mean Age
|
99999999
|
Total
|
8.9
|
Age Continuous
|
weeks
|
|
Standard Deviation Age
|
99999999
|
Total
|
2.3
|
Age Continuous
|
weeks
|
|
Median Age
|
1
|
Treatment Arm 1
|
9
|
Study Specific Characteristic |
weeks
|
|
Age Min
|
1
|
Treatment Arm 1
|
6
|
Study Specific Characteristic |
weeks
|
|
Age Max
|
1
|
Treatment Arm 1
|
11
|
Study Specific Characteristic |
weeks
|
|
Median Age
|
2
|
Treatment Arm 2
|
9
|
Study Specific Characteristic |
weeks
|
|
Age Min
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
weeks
|
|
Age Max
|
2
|
Treatment Arm 2
|
14
|
Study Specific Characteristic |
weeks
|
|
Median Age
|
99999999
|
Total
|
9
|
Study Specific Characteristic |
weeks
|
|
Age Min
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
weeks
|
|
Age Max
|
99999999
|
Total
|
14
|
Study Specific Characteristic |
weeks
|
|
WHITE
|
1
|
Treatment Arm 1
|
3
|
Race, Customized
|
Participants
|
|
WHITE
|
2
|
Treatment Arm 2
|
195
|
Race, Customized
|
Participants
|
|
WHITE
|
99999999
|
Total
|
198
|
Race, Customized
|
Participants
|
|
OTHER
|
1
|
Treatment Arm 1
|
0
|
Race, Customized
|
Participants
|
|
OTHER
|
2
|
Treatment Arm 2
|
1
|
Race, Customized
|
Participants
|
|
OTHER
|
99999999
|
Total
|
1
|
Race, Customized
|
Participants
|
|
Median Weight
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Min
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Max
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Median Weight
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Min
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Max
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Median Weight
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Min
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Weight Max
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Mean Weight
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Standard Deviation Weight
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Mean Weight
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Standard Deviation Weight
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Mean Weight
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Standard Deviation Weight
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
Kilograms
|
|
Median Height
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Min
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Max
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
centimeters
|
|
Median Height
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Min
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Max
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
centimeters
|
|
Median Height
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Min
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
centimeters
|
|
Height Max
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
centimeters
|
|
Mean Height
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
centimeters
|
|
Standard Deviation Height
|
1
|
Treatment Arm 1
|
0
|
Study Specific Characteristic |
centimeters
|
|
Mean Height
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
centimeters
|
|
Standard Deviation Height
|
2
|
Treatment Arm 2
|
0
|
Study Specific Characteristic |
centimeters
|
|
Mean Height
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
centimeters
|
|
Standard Deviation Height
|
99999999
|
Total
|
0
|
Study Specific Characteristic |
centimeters
|
|
TOTAL
|
1
|
Treatment Arm 1
|
3
|
Study Specific Characteristic |
|
|
TOTAL
|
2
|
Treatment Arm 2
|
196
|
Study Specific Characteristic |
|
|
TOTAL
|
99999999
|
Total
|
199
|
Study Specific Characteristic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Corresponding Data Entry for Baseline Characteristics
|
|
|
|
|
|
|
|
|
Parameter Name
|
PARAM
|
|
|
|
|
|
|
|
Treatment Group ID
|
ARM_GROUP_ID
|
|
|
|
|
|
|
|
Treatment Group
|
ARM_GROUP_TITLE
|
|
|
|
|
|
|
|
Parameter Value
|
AVAL
|
|
|
|
|
|
|
|
Measure Title
|
MEASURE_TITLE
|
|
|
|
|
|
|
|
Unit of Measure
|
UNITOFM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Participant Flow Dataset
|
|
|
|
|
|
MILESTONE
|
TRTAN
|
TRTA
|
COUNT
|
WITHDRAW_REASON
|
OTHER_REASON
|
PERIOD
|
Started
|
1
|
Drug A
|
10
|
|
|
Treatment
|
Completed
|
1
|
Drug A
|
5
|
|
|
Treatment
|
Withdrew
|
1
|
Drug A
|
2
|
Adverse Events
|
|
Treatment
|
Withdrew
|
1
|
Drug A
|
1
|
Deaths
|
|
Treatment
|
Withdrew
|
1
|
Drug A
|
2
|
other_dc
|
Global deterioration of health status
|
Treatment
|
Started
|
2
|
Drug B
|
10
|
|
|
Treatment
|
Completed
|
2
|
Drug B
|
5
|
|
|
Treatment
|
Withdrew
|
2
|
Drug B
|
2
|
Adverse Events
|
|
Treatment
|
Withdrew
|
2
|
Drug B
|
1
|
Deaths
|
|
Treatment
|
Withdrew
|
2
|
Drug B
|
2
|
other_dc
|
Global deterioration of health status
|
Treatment
|